Clinical trials
Completed Endocrine System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
83 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 9 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 83 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Center for Research Resources (NCRR) | 8 |
| AstraZeneca | 6 |
| University of Pittsburgh | 5 |
| Ascendis Pharma Endocrinology Division A/S | 4 |
| Eli Lilly and Company | 4 |
| Ascendis Pharma A/S | 2 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| Goldfinch Bio, Inc. | 2 |
| Jaeb Center for Health Research | 2 |
| M.D. Anderson Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine System Diseases | 83 |
| Diabetes Mellitus | 29 |
| Glucose Metabolism Disorders | 27 |
| Metabolic Diseases | 25 |
| Diabetes Mellitus, Type 2 | 20 |
| Rare Diseases | 12 |
| Autoimmune Diseases | 8 |
| Dwarfism, Pituitary | 7 |
| Hypogonadism | 6 |
| Neoplasms | 6 |
Trials
Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.